deltatrials
Unknown PHASE2 NCT00044226

A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia

Sponsor: Milkhaus Laboratory

Conditions Prostatic Hyperplasia
Interventions ML-04A
Updated 5 times since 2017 Last updated: Jun 23, 2005 Started: Apr 30, 2002 Completion: Oct 31, 2002

This PHASE2 trial investigates Prostatic Hyperplasia and is currently ongoing. Milkhaus Laboratory leads this study, which shows 5 recorded versions since 2002 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE2

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Unknown Status PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Unknown Status PHASE2

    First recorded

Apr 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Milkhaus Laboratory
Data source: Milkhaus Laboratory

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aurora, United States, Bay Shore, United States, Clearwater, United States, Fair Oaks, United States, Fort Worth, United States, Las Vegas, United States, Mobile, United States, Ocala, United States, Richmond, United States, Rockville, United States and 4 more location s